Fund Twenty8

EnteroBiotix Limited is a biotechnology company based in Edinburgh, United Kingdom, founded in 2017. It specializes in researching, developing, and commercializing orally available products for fecal microbiota transplantation. The company creates microbiome-modulating drugs composed of bacterial communities derived from the human gastrointestinal tract, aimed at restoring health and preventing bacterial infections. EnteroBiotix focuses on addressing serious unmet medical needs by offering tailored high-diversity microbial therapeutics, which help physicians prevent and treat debilitating infections and diseases linked to imbalances in gut bacteria.

Liopa Ltd is a Belfast-based company that specializes in biometric authentication and verification technology. Established in 2015, it has developed LipVerify, a solution that validates user identity by analyzing lip movements as they speak into a camera. Drawing from over 15 years of PhD research in speech and image processing, Liopa has created an automated lipreading technology rooted in machine learning and artificial intelligence. The company is notable for introducing commercially available visual speech recognition technology, with its primary application being SRAVI. This smartphone app is designed to assist individuals who have lost their ability to speak, enabling them to communicate by deciphering their lip movements. SRAVI is currently undergoing trials in Intensive Care units within the NHS, providing a crucial communication tool for patients and their caregivers.

SupaPass is an all-in-one website and app creation platform for any business to launch its own website and apps. SupaPass allows anyone to create beautiful and powerful, payment-ready, all-in-one content website and mobile apps instantly without any technical knowledge. With millions of individuals and businesses globally needing a launch-ready, affordable content driven website and app, SupaPass is an innovative white-label platform that allows clients to retain 100% of sales and full ownership of customer data at the touch of a button. It offers more cost-effective and intuitive designs to make content such as podcasts, video, audio and streaming channels more manageable, it is over 10 times faster and cheaper than custom-built solutions. With SupaPass’s technology clients are able to keep their own brand front and control how they interact with their customers. With a content layout similar to Netflix and Prime, SupaPass gives clients the tools they need to have everything in one place to grow their business online. It services a wide range of sectors and verticals including Podcasting, Fitness, and Wellbeing, TV and Film, Archives, Membership Organisations, Music, Sport, Charities, Conferences, and Consultancies. SupaPass was founded in 2011.

Lightpoint Medical, Ltd. is a medical device company based in Rickmansworth, United Kingdom, founded in 2012. The company specializes in developing innovative imaging technologies for cancer surgery, particularly through its Cerenkov Luminescence Imaging (CLI) technology. This breakthrough intraoperative imaging tool allows for real-time detection of cancer during surgical procedures, which can significantly reduce the chances of cancer recurrence and the necessity for reoperations. By optimizing the performance of robotic cancer surgery, Lightpoint Medical aims to provide healthcare professionals with advanced tools that enhance surgical decision-making and improve patient outcomes, ultimately contributing to cost savings within the healthcare system.

MGB Biopharma Limited is a biopharmaceutical company based in Bellshill, United Kingdom, specializing in the development of a new class of anti-infective medicines derived from minor groove binder compounds. Established in 2009, the company focuses on creating small molecules with specific antibacterial properties to combat both multi-resistant and susceptible Gram-positive bacteria. One of its key products, MGB-BP-3, is an antibacterial agent designed for the oral treatment of Clostridium difficile-associated disease. MGB Biopharma aims to address the challenges of antibiotic resistance by employing a novel mode of action that targets bacteria lacking inherent resistance mechanisms, offering a promising approach to treating bacterial infections effectively.

Gelmetix Limited specializes in developing injectable gel-based therapeutic biomaterials aimed at addressing bone disorders and early-stage degenerative disc disease. Founded in 2012 and based in Nether Alderley, United Kingdom, with additional offices in London, Manchester, and Paris, the company offers a range of microgel therapies designed as non-invasive alternatives to surgery for conditions such as chronic low back pain and osteoarthritis. Its lead product is a hydrogel specifically formulated for nucleus pulposus augmentation, which targets chronic lower back pain by being injected into the intervertebral disc to relieve pain and restore functionality during the early stages of degeneration. This innovative approach aims to provide patients with effective pain relief and to prevent further degeneration of the intervertebral disc.

Naked Energy Ltd., founded in 2009 and based in Crawley, United Kingdom, specializes in the manufacture of innovative hybrid solar technology that generates both electricity and heat for various applications. The company's flagship product, Virtu®, utilizes a modular design that incorporates crystalline photovoltaic cells within an evacuated solar thermal collector. This approach allows for the conversion of a significant portion of solar energy—up to 80% of the available 1000W/m2—into usable heat and electricity, regardless of geographic or climatic conditions. The technology is particularly advantageous in urban settings with limited space, making it suitable for a range of customers, including hotels, hospitals, and manufacturing facilities. Naked Energy is in the final stages of preparing for the commercial launch of this scalable and disruptive solution, which aims to enhance energy efficiency and reduce consumption in both domestic and industrial markets.

MeasureMatch operates an on-demand professional services marketplace designed to connect business leaders with independent service providers for systems and data project work. The platform facilitates access to a vast network of over 10,000 consultancies, agencies, systems integrators, and independent consultants specializing in B2B cloud software implementations, data management, analytics, and AI professional services. Through its two core products, AtlasGM and the MeasureMatch Marketplace, the company enables businesses to implement crucial services such as data infrastructure, analytics, marketing technology, and CRM data. This approach helps organizations enhance their marketing, commerce, and customer experience capabilities, streamlining the process of matching needs with expertise.

Pass the Keys Limited is a property management company based in London, specializing in Airbnb and short-term rental management services across the United Kingdom. Established in 2015, the company offers a comprehensive range of services that include listing preparation, guest screening and communication, 24/7 guest support, key management, and thorough cleaning and laundry services. By listing properties on platforms like Airbnb, Pass the Keys aims to maximize occupancy and rental income for landlords while minimizing their workload. The company employs technology to enhance operational efficiency and provides detailed accounting and reporting to its clients. With its extensive experience and a network of dedicated franchisees, Pass the Keys seeks to create opportunities for hosts and guests alike, establishing itself as a leading player in the short-term rental market.

Metrion Biosciences Ltd is a contract research organization based in Cambridge, United Kingdom, specializing in drug discovery services for pharmaceutical and bioscience clients globally. Established in 2015, the company provides a range of preclinical screening services, with a focus on ion channel screening, cardiac safety profiling, neuroscience assays, and translational assays. Metrion's platform offers skilled electrophysiology services in various formats, supporting medicinal chemistry optimization. The organization employs flexible business models, allowing clients to choose between fee-for-service and collaborative options, as well as access to integrated drug discovery services tailored to the specific needs of each program.

Cyance Limited is a predictive marketing technology company based in Oxfordshire, United Kingdom, specializing in B2B solutions. Founded in 2007, Cyance offers the Nexus platform, a software-as-a-service (SaaS) tool that tracks online research and buying behaviors of B2B organizations globally. This platform integrates intent data from various online sources, including social media and advertising networks, to generate insights that help businesses identify and engage potential customers more effectively. By analyzing behavior signals, Cyance enables brands to refine their marketing strategies and improve the efficiency of their sales efforts, ultimately enhancing conversion rates and return on investment for demand generation and account-based marketing initiatives.

PatientSource is a developer of clinical software and electronic medical record systems aimed at enhancing patient safety and quality of care. The platform facilitates the secure transmission of patient information, including referrals and discharge letters, through various communication methods such as secure emails and instant messaging. By integrating clinical pathways with multidisciplinary teams, PatientSource seeks to reduce clinician burnout and frustration, ultimately improving the overall efficiency of healthcare delivery.

We became frustrated by banks and other lenders holding back the growth of small businesses due to their inflexible rules about who they will lend to. We realised that for many small businesses who need funding, fintechs and challenger banks are not filling the funding gap; because they use many of the same rules as the banks. Yet over 99.9% of UK businesses are small businesses, employing over 60% of the private sector workforce. Independent research tells us that the funding gap is at least £2.2bn per year and could be as much as £35bn1. Knowing that small businesses have such a great impact upon local economies, job creation and social mobility, we felt compelled to do something. We partnered with many other organisations similarly passionate about sustainably, ethically and commercially tackling the funding gap for small businesses, and Ask Inclusive Finance was born...A platform based marketplace for loans to financeable small companies unable to secure bank funding. Launched in partnership with lenders, funders and other industry stakeholders.

Pekama is a company that offers a cloud-based platform to assist businesses in managing their intellectual property (IP) effectively. The platform enables users to access their existing IP and create personalized IP dashboards in a matter of seconds, facilitating data-driven decision-making and strategic planning. Additionally, Pekama provides accurate cost estimates for new and existing patents and trademarks, allowing clients to evaluate expenses for various IP services globally. By streamlining the filing process and offering instant price estimates, Pekama enhances collaboration between lawyers and clients, ultimately simplifying the management of intellectual property.

GreenSpur develops a new rare earth-free generator for the global offshore wind market. The company's generator uses ferrite magnets to generate cheap energy, enabling wind turbine markets to improve efficiency and produce renewable energy at affordable prices.

Ambicare Health Ltd specializes in developing wearable light sources for medical and consumer healthcare applications. The company offers innovative products such as Ambulight PDT, a light-emitting sticking plaster designed for treating non-melanoma skin cancer using photodynamic therapy, which serves as a non-surgical alternative. Additionally, Ambicare Health provides blue light therapy solutions, including Lustre Pure Light Classic and Lustre Pure Light Pro, which are effective in combating spots and acne. These products are distributed through various channels, including online sales and partnerships with distributors. Founded in 2004 and based in Livingston, United Kingdom, Ambicare Health was formerly known as Lumicure Ltd before rebranding in 2009.

Interpac has developed a new packaging production system the corrugator which does not use steam in the manufacturing process. The Interpac system is a revolutionary process that enables on-demand production which significantly reduces packaging costs and emits 90% less greenhouse gases than conventional processes.

Kulea provides business development, email deliverability, prospecting and data, and martech integration services. They offer marketing automation software, email marketing, persona-powered marketing, and website landing pages and forms.

LuckyTrip is a travel aggregation and booking application that leverages artificial intelligence to help users discover unique holiday options with ease. The app allows users to set their budget and, with a single tap of the "Lucky" button, presents them with various travel destinations across Europe. By scanning multiple travel sites, LuckyTrip generates a range of choices that include low-cost flights, suitable accommodations, and diverse travel experiences, making it particularly appealing to millennial tourists. This streamlined approach to trip planning enables users to conveniently explore and book their ideal holiday, all from their mobile devices.

Bockatech specializes in EcoCore, a patented technology designed for foam plastic injection molding. This innovative solution supports leading food service and fast-moving consumer goods (FMCG) brands in producing insulated, reusable, and recyclable packaging that is also cost-effective. EcoCore enhances the strength of packaging while minimizing the amount of plastic required, making it applicable across various sectors, including retail food, caps and closures, and healthcare. The technology is currently utilized in reusable food service products across Europe and is integral to the global initiatives of major FMCG companies aimed at reducing plastic usage, such as reusable coffee cup programs. Bockatech's EcoCore technology has earned recognition from the Solar Impulse Efficient Solution label and the Ellen MacArthur Foundation, highlighting its potential to aid businesses and governments in achieving environmental sustainability goals.

CamNutra’s mission is to protect people against chronic health conditions using proprietary natural healthcare products which are clinically-proven by the world’s leading research institutions. CamNutra’s first product is Ateronon, which has been developed to protect against cardiovascular disease. It is the result of over £12m of development and has been the subject of clinical testing by teams from each of Cambridge and Harvard Universities. Research by Cambridge University published in June 2014 showed Ateronon to give a significant improvement in endothelial function in patients already taking statins. Ateronon is protected by a number of patents and is a naturally modified and highly bioavailable form of lycopene, which is a carotenoid derived from tomatoes. Ateronon is sold as an over the counter healthcare supplement both through www.ateronon.com as well as through the major retailers in the UK such as Holland & Barrett, Boots, J Sainsbury and Morrisons. The company has signed distribution deals in several overseas markets. CamNutra has a pipeline of further innovative, science-based natural healthcare products with intellectual property protection and clinically-proven benefit which it plans to bring to market. New products cover health indications such as cardiovascular disease, prostate health, diabetes and metabolic syndrome. CamNutra was formed in 2011 to acquire the IP and related assets of Ateronon and other innovative natural healthcare products. In 2012-13, the company received a total of £1.6m from the Cambridge Angels group of investors and having established a fast-growing sales base, is now in the process of raising further funds to accelerate its product roll-out and the development of its product pipeline.

NextUp is a subscription-based video streaming platform that focuses on live stand-up comedy, providing users with access to a diverse range of exclusive shows. The platform features performances from well-known comedians as well as emerging talent, covering various styles such as sketch acts, character-based humor, storytelling, and observational comedy. By offering a 30-day free trial and a flexible subscription model, NextUp aims to make comedy accessible while supporting comedians and the venues that host them. The service has earned recognition for its expansive library, which allows subscribers to discover new acts and enjoy a wide spectrum of the live comedy circuit.

SupaPass is an all-in-one website and app creation platform for any business to launch its own website and apps. SupaPass allows anyone to create beautiful and powerful, payment-ready, all-in-one content website and mobile apps instantly without any technical knowledge. With millions of individuals and businesses globally needing a launch-ready, affordable content driven website and app, SupaPass is an innovative white-label platform that allows clients to retain 100% of sales and full ownership of customer data at the touch of a button. It offers more cost-effective and intuitive designs to make content such as podcasts, video, audio and streaming channels more manageable, it is over 10 times faster and cheaper than custom-built solutions. With SupaPass’s technology clients are able to keep their own brand front and control how they interact with their customers. With a content layout similar to Netflix and Prime, SupaPass gives clients the tools they need to have everything in one place to grow their business online. It services a wide range of sectors and verticals including Podcasting, Fitness, and Wellbeing, TV and Film, Archives, Membership Organisations, Music, Sport, Charities, Conferences, and Consultancies. SupaPass was founded in 2011.

Peptinnovate Ltd is a drug development company based in Stevenage, United Kingdom, focused on researching and developing immune regulating therapies for asthma and various immuno-inflammatory diseases, including atopic dermatitis and inflammatory bowel disease. Founded in 2011, the company leverages a unique biotechnology inspired by the mechanisms employed by Mycobacterium tuberculosis to evade the host immune system and modulate inflammatory responses. Through its innovative approach, Peptinnovate aims to address unmet medical needs in the treatment of these chronic conditions.